WYE VALLEY PHARMA LTDActive

Company number 11961684Private limited companyIncorporated 2019

Key figures

£693,474+185.0%
Net assets 2024/25
+127.7%
Average annual growth 2019/20–2024/25
-200 k0200 k400 k600 k800 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, WYE VALLEY PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand158,362158,362559,702395,964395,964
Total assets372,919372,9191,110,5901,440,3833,564,063
Total liabilities732,082732,0821,076,0731,197,0692,870,589
Net assets / total equity-9,163-9,16334,517243,314693,474
Average number of employees00666

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: WYE VALLEY PHARMA LTD

Company

WYE VALLEY PHARMA LTD is a private limited company registered with Companies House under company number 11961684. It was incorporated on 24 Apr 2019. Its status is active. The registered office is in Huddersfield (HD1). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files abridged accounts (unaudited). Net assets were £693,474, up 185% on the previous year. Cash at bank and in hand was £395,964. Total assets were £3,564,063 and total liabilities £2,870,589. The company had an average of 6 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

4 of 4 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 7 May 2027.